Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ImClone’s Late-stage Pipeline Includes A Potential Erbitux Competitor

Aug 05 2008

• By Shirley Haley

Related Content

Is Bristol-Myers Squibb’s ImClone Takeover Bid A Preemptive Grab?

Aug 04 2008

Bristol-Myers Squibb Eyes A Jewel To Add To Its String Of Pearls

Jul 31 2008

ImClone Metastatic Breast Cancer Candidate Moves Into Phase III In Third Quarter

Apr 22 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window